Changing How You Think About Precision Diagnostics

We're building the operating system for pathology—a unified platform for advanced storage, seamless viewing, and clinical-grade AI that makes the future possible, today.

Watch Demo Video

One Platform. Every Format. 60% Less Storage.

Scanner Neutral. Vendor Neutral. AI Neutral. Our platform is built to work with everything you already have—and make it significantly better.

True Vendor Neutrality

We don't lock you into specific scanners, vendors, or AI providers. Handle every format from every manufacturer. SVS, NDPI, MRXS, SCN, and more—our platform supports them all equally.

Patented Compression

Our storage technology reduces file sizes by more than 60% losslessly. A typical 2GB slide becomes less than 800MB with zero compromise in diagnostic quality. This isn't incremental improvement—it's a breakthrough.

Works With Everything You Have

  • Scanner Neutral - Compatible with all major WSI scanners
  • Vendor Neutral - No proprietary lock-ins, open architecture
  • AI Neutral - Run any AI model, from any provider, or build your own
  • Microscope Universal - Connect any microscope camera and start immediately
Learn About Our Technology

Upgrade Your Microscope Into a Next-Generation Diagnostic Tool

Transform your traditional microscope into an AI-powered diagnostic system with our platform.

AI Right in Your Workflow

No more switching between microscope and computer. Our platform brings AI directly into your viewing experience—insights appear in real-time as you navigate the slide.

See More, Know More, Instantly

  • Live AI Overlays - Regions of interest highlight automatically
  • Real-Time Quantification - Cell counts and biomarker expression as you scan
  • Digital Capture - Build whole slide images on-the-fly while examining tissue

From Analog to AI in Minutes

Simply connect your microscope camera to our platform. No special equipment. No complex setup. Just immediate AI enhancement of your existing workflow.

Watch Live Demo

Artificial Intelligence. Actual Results.

Clinical AI, validated and available today.

Breast Cancer Suite

Our comprehensive analysis delivers results within 5% of pathologist ground truth. Biomarker Quantification includes:

  • ER Scoring - Allred and H-score with ±5% accuracy
  • PR Scoring - Comprehensive assessment matching expert pathologists
  • KI67 Index - Proliferation analysis with hot-spot detection

Colon Cancer Suite

Our AI predicts microsatellite instability status directly from routine H&E images—no special stains, no molecular testing, no waiting.

  • Features a 98% Negative Predictive Value
  • Confidently rule out MSI-high cases, focusing molecular testing only where it's truly needed.

We Are Turocrates

Flexible

Scanner neutral. Vendor neutral. AI neutral. Your platform, your choice.

Real-Time

Live AI at the microscope. Instant insights. No delays.

Everything Microscope

From traditional viewing to AI-powered analysis, we make your microscope the center of precision diagnostics.

Join the Precision Diagnostics Movement

We're selecting forward-thinking institutions for our Early Access Program.

What's Included:

  • Full platform access with patented storage technology
  • Live microscope AI integration
  • Breast cancer & Colon cancer suites
  • Priority support and training
  • Preferred pricing locked for life
Request Early Access

Applications are reviewed weekly. We prioritize institutions ready to advance their diagnostic capabilities.

For AI Vendors

Port your algorithm once, deploy everywhere. Reach more pathologists, faster.

Why Partner with Turocrates

  • No Integration Hassle - We handle deployment, you focus on AI
  • Scanner Neutral - Your algorithm works across all formats automatically
  • Real-Time Deployment - From upload to production in days, not months

What We Provide

  • Standardized API for seamless integration
  • Automatic format conversion and compatibility
  • Performance monitoring and analytics
  • Billing, license management, and end-user support
AI Vendor Application

We're actively onboarding clinical-grade, validated algorithms.